Medical Affairs 2.0: Innovating Medical Affairs for Digital Therapeutics

Medical Affairs 2.0: Innovating Medical Affairs for Digital Therapeutics

Objectives:

· Present an overview of the current and near term Digital Therapeutics landscape with a focus on current stages of development.

· Review the impact of COVID-19 as an accelerator for the development and use of Digital Therapeutics.

· Detail real world applications of Digital Therapeutics to illustrate the potential it holds in driving transformation of clinical practices to improve patient outcomes.

· Examine how Medical Affairs can help act as a strategic partner and shape the trajectory of the Digital Therapeutics pipeline and life-cycle.

MODERATOR: Conor Schmitt

Engagement Manager, SSI Strategy

Career management consultant with 7+ years of experience, current focus is on on advising Chief Medical Officers on the development of Medical Affairs functions.